347 related articles for article (PubMed ID: 19878081)
1. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
[TBL] [Abstract][Full Text] [Related]
3. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells.
Ma N; Ladilov Y; Moebius JM; Ong L; Piechaczek C; Dávid A; Kaminski A; Choi YH; Li W; Egger D; Stamm C; Steinhoff G
Cardiovasc Res; 2006 Jul; 71(1):158-69. PubMed ID: 16730684
[TBL] [Abstract][Full Text] [Related]
4. Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.
Sanchez-Guijo FM; Oterino E; Barbado MV; Carrancio S; Lopez-Holgado N; Muntion S; Hernandez-Campo P; Sanchez-Abarca LI; Perez-Simon JA; San Miguel JF; Briñon JG; del Cañizo MC
Cell Transplant; 2010; 19(1):103-12. PubMed ID: 19818207
[TBL] [Abstract][Full Text] [Related]
5. [Transplantation of cord blood endothelial progenitor cells ameliorates limb ischemia].
Yang C; Zhang ZH; Lu SH; Yang RC; Qian GQ; Han ZC
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1437-41. PubMed ID: 14521750
[TBL] [Abstract][Full Text] [Related]
6. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
[TBL] [Abstract][Full Text] [Related]
7. CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis.
Elkhafif N; El Baz H; Hammam O; Hassan S; Salah F; Mansour W; Mansy S; Yehia H; Zaki A; Magdy R
APMIS; 2011 Jan; 119(1):66-75. PubMed ID: 21143528
[TBL] [Abstract][Full Text] [Related]
8. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation.
Donndorf P; Useini D; Lux CA; Vollmar B; Delyagina E; Laupheimer M; Kaminski A; Steinhoff G
Cell Transplant; 2013; 22(9):1627-35. PubMed ID: 23051098
[TBL] [Abstract][Full Text] [Related]
9. Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord.
Kamei N; Kwon SM; Alev C; Nakanishi K; Yamada K; Masuda H; Ishikawa M; Kawamoto A; Ochi M; Asahara T
J Neurol Sci; 2013 May; 328(1-2):41-50. PubMed ID: 23498368
[TBL] [Abstract][Full Text] [Related]
10. Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.
Ascione R; Rowlinson J; Avolio E; Katare R; Meloni M; Spencer HL; Mangialardi G; Norris C; Kränkel N; Spinetti G; Emanueli C; Madeddu P
Stem Cell Res Ther; 2015 Apr; 6(1):53. PubMed ID: 25889213
[TBL] [Abstract][Full Text] [Related]
11. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
[TBL] [Abstract][Full Text] [Related]
12. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
[TBL] [Abstract][Full Text] [Related]
13. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
14. Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells.
Reich DM; Hau S; Stahl T; Scholz M; Naumann W; Emmrich F; Boltze J; Kamprad M
BMC Neurosci; 2008 Sep; 9():91. PubMed ID: 18803816
[TBL] [Abstract][Full Text] [Related]
15. Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury.
Putman DM; Liu KY; Broughton HC; Bell GI; Hess DA
Stem Cells; 2012 Oct; 30(10):2248-60. PubMed ID: 22899443
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells.
Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA
Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia.
López-Holgado N; Alberca M; Sánchez-Guijo FM; Villarón EM; Rivas JV; López-Novoa JM; Briñón JG; Arévalo MA; Oterino E; Santamaría C; San Miguel JF; del Cañizo MC
Cytotherapy; 2009; 11(8):1041-51. PubMed ID: 19929468
[TBL] [Abstract][Full Text] [Related]
18. Age-related BM-MNC dysfunction hampers neovascularization.
Sugihara S; Yamamoto Y; Matsuura T; Narazaki G; Yamasaki A; Igawa G; Matsubara K; Miake J; Igawa O; Shigemasa C; Hisatome I
Mech Ageing Dev; 2007 Sep; 128(9):511-6. PubMed ID: 17688912
[TBL] [Abstract][Full Text] [Related]
19. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model.
Sasaki H; Ishikawa M; Tanaka N; Nakanishi K; Kamei N; Asahara T; Ochi M
Spine (Phila Pa 1976); 2009 Feb; 34(3):249-54. PubMed ID: 19148043
[TBL] [Abstract][Full Text] [Related]
20. CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood.
Pelagiadis I; Relakis K; Kalmanti L; Dimitriou H
Cytotherapy; 2012 Jul; 14(6):701-6. PubMed ID: 22413760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
